Despite the paradoxical nature of the change, the upregulation of Abca1 was recently found to ameliorate neurodegeneration and neuroinflammation in a tauopathy model, suggesting potential beneficial effects of 24S-HC reduction [48]. The gene discussed is ABCA1; the disease is tauopathy.